Which of the following is a very long acting Beta 2- agonist
The options aren't listed, but I know the common Beta 2-agonists. Short-acting ones are like albuterol (salbutamol) and terbutaline. They work quickly but don't last long. Then there are long-acting ones, which are used for maintenance. The long-acting ones include salmeterol and formoterol. Wait, but sometimes people confuse formoterol as being a bit faster onset than salmeterol. But both are considered long-acting.
Now, the term "very long-acting" might be a trick here. Are there any Beta 2-agonists with even longer durations? I think there's vilanterol, which is used in combination with fluticasone in some inhalers. Vilanterol has a longer duration than salmeterol. Also, indacaterol is another one, which is once-daily. So maybe the correct answer is indacaterol or vilanterol.
The options probably include salmeterol, formoterol, albuterol, and maybe one of the newer ones. Let me check the durations. Salmeterol is 12 hours, formoterol is around 12 hours as well. Vilanterol and indacaterol have longer durations. So if the question is about "very long-acting," then the answer would be one of these newer agents.
Wait, the user didn't provide the options. But based on standard knowledge, the correct answer is likely indacaterol or vilanterol. Let's assume the options are A. Salmeterol, B. Formoterol, C. Albuterol, D. Indacaterol. Then the correct answer is D. Indacaterol.
Now, why are the other options incorrect? Salmeterol and formoterol are long-acting but not very long. Albuterol is short-acting. So the explanation would have to clarify the duration of each and why the correct one is considered very long. Also, mention that the newer agents have longer durations and are used once daily, unlike the older long-acting ones which are twice daily.
Clinical pearls: Remember that SABA (short-acting) are for rescue, LABA (long-acting) for maintenance. The newer very long-acting ones are once-daily and used in combination with ICS for better control.
**Core Concept**
Beta-2-agonists are bronchodilators that stimulate beta-2 adrenergic receptors in bronchial smooth muscle. Long-acting beta-2-agonists (LABAs) like **salmeterol** and **formoterol** provide 12-hour relief, while **very long-acting beta-2-agonists (VLABAs)** such as **indacaterol** and **vilanterol** offer 24-hour efficacy and are administered once daily.
**Why the Correct Answer is Right**
**Indacaterol**